Risk Factors Update Summary
- Market capitalization decreased from $49 million to $33 million, with stockholders' equity decreasing from $108 million to $99.3 million.
- Sales of VanishPoint syringes decreased from 91% to 78% of total sales in 2023.
- The number of employees at Embecta increased from 900 to 200 in 2023.
- The percentage of products produced by Chinese manufacturers decreased from 91% to 88% in 2023.
- International sales revenue decreased from 44% to 20% of total revenues in 2023.
- Ownership stake by Mr. Shaw increased from 51% to 50% in 2024, potentially impacting business decisions.
- Inflationary pressures and uncertain commodity availability could negatively impact operating results.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=946563&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.